Skip to main content

Table 2 Risk factors associated with deterioration

From: Maximum chest CT score is associated with progression to severe illness in patients with COVID-19: a retrospective study from Wuhan, China

 

Univariable OR (95% CI)

p value

Multivariable OR (95% CI)

p value

Characteristics

 Age, years

   < 60

1 (ref)

 

1 (ref)

 

   ≥ 60

2.84 (1.41–5.72)

0.003

1.48 (0.54–4.05)

0.444

 Sex (vs. female)

2.00 (1.01–3.97)

0.048

  

Symptoms

0

   

 Chest tightness

3.01 (1.47–6.16)

0.003

0.85 (0.32–2.78)

0.918

Laboratory findings

 White blood cell count, ×109/L

   < 10

1 (ref)

   

   ≥ 10

1.03 (0.87–18.77)

0.075

  

 Lymphocyte count, ×109/L

   < 1

1 (ref)

   

   ≥ 1

0.55 (0.28–1.10)

0.092

  

 Monocyte count, ×109/L

   < 0.5

1 (ref)

   

   ≥ 0.5

1.33 (0.62–2.87)

0.47

  

 D-dimer, mg/L

   < 1

1 (ref)

 

1 (ref)

 

   ≥ 1

3.11 (1.46–6.62)

0.003

1.82 (0.62–0.21)

0.388

 C-reactive protein, mg/L

   < 1

1 (ref)

   

   ≥ 1

2.07 (1.02–4.19)

0.043

0.62 (0.21–1.84)

0.276

 α-hydroxybutyrate dehydrogenase, U/L

   < 180

1 (ref)

   

   ≥ 180

4.72 (2.27–9.83)

< 0.001

  

 Lactate dehydrogenase, U/L

   < 250

1 (ref)

   

   ≥ 250

6.44 (3.05–13.62)

< 0.001

  

 Creatine kinase, U/L

   < 190

1 (ref)

 

1 (ref)

 

   ≥ 190

3.23 (1.37–7.61)

0.007

1.20 (0.31–4.63)

0.792

 Creatinine, μmol/L

   < 97

1 (ref)

 

1 (ref)

 

   ≥ 97

4.09 (1.46–11.51)

0.008

2.43 (0.56–10.50)

0.235

 NLR

1.13 (1.04–1.23)

0.003

1.09 (0.98–1.21)

0.105

Comorbidities (vs no)

 Any

3.89 (1.89–8.01)

< 0.001

1.95 (0.58–6.51)

0.278

 Hypertension

3.46 (1.64–7.31)

0.001

0.67 (0.17–2.61)

0.567

 Chronic obstructive pulmonary disease

5.66 (1.56–20.56)

0.008

9.06 (1.30–63.36)

0.026

Imaging features

 Initial CT score, median (IQR)

1.07 (0.97–1.17)

0.184

  

 Maximum CT score, median (IQR)

1.40 (1.26–1.56)

< 0.001

1.39 (1.21–1.60)

< 0.001

Others

 Onset of symptoms to hospital, median (IQR), days

1.03 (0.94–1.13)

0.507

  

 Hospital stay, median (IQR), days

1.07 (1.03–1.12)

0.002

  

 Time from illness onset to highest CT score, median (IQR), days

1.15 (1.07–1.23)

< 0.001

  
  1. Data are mean (SD), median (IQR), n (%) or n/N (%). NLR Neutrophil Lymphocyte Ratio; SD standard deviation; OR odds ratio; IQR interquartile range; CI confidence interval